Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Idarubicin HCl: Lab Handling & Research Use Guide

Idarubicin HCl is a semi-synthetic anthracycline antibiotic and potent topoisomerase II inhibitor widely employed in cancer biology research to induce DNA double-strand breaks and apoptosis in tumor cell models.

Chemical Class
Anthracycline antibiotic
Primary Mechanism
Topoisomerase II inhibition and DNA intercalation
Molecular Formula
C26H28ClNO9 (HCl salt)
Appearance
Orange-red crystalline powder
Solubility
Soluble in water and DMSO; prepare stock solutions at ≥10 mM
Storage Conditions
Store desiccated at -20 °C, protected from light
Research Application
In vitro cytotoxicity assays, apoptosis studies, DNA damage models

Overview and Mechanism of Action

Idarubicin HCl (I408285) is a semi-synthetic derivative of daunorubicin in the anthracycline family. Unlike its parent compound, idarubicin lacks the methoxy group at the C-4 position of the aglycone ring, which confers greater lipophilicity and enhanced cellular uptake.

Its primary mechanism of action involves intercalation into double-stranded DNA, whereby the planar aglycone ring system inserts between adjacent base pairs. This physical intercalation distorts the DNA helix and inhibits the catalytic activity of topoisomerase II, preventing the religation of DNA strand breaks generated during replication and transcription. The resulting accumulation of DNA double-strand breaks triggers downstream apoptotic signaling cascades, including activation of caspases and release of cytochrome c from mitochondria.

In research settings, Idarubicin HCl is frequently used to establish DNA damage response models, to study cell cycle arrest at G2/M phase, and to investigate intrinsic apoptotic pathways in hematological and solid tumor cell lines.

Physical & Chemical Properties

Idarubicin HCl presents as an orange-red crystalline powder with the molecular formula C26H28ClNO9 and a molecular weight of approximately 533.96 g/mol. It is the hydrochloride salt form, which improves aqueous solubility compared to the free base.

Key physicochemical characteristics relevant to laboratory use include:

  • Solubility: Freely soluble in water (≥10 mg/mL) and soluble in DMSO. Ethanol may be used as a co-solvent for certain formulations. Avoid prolonged exposure to alkaline conditions, which can degrade the glycosidic bond.
  • Stability: Solutions are photosensitive; always prepare and handle stock solutions under subdued or amber lighting. Aqueous solutions should be used promptly or stored at -20 °C in aliquots.
  • Color: The characteristic orange-red color provides a visual indicator of compound integrity; significant color change may indicate degradation.
  • pKa: The daunosamine amino group is protonated at physiological pH, contributing to DNA binding affinity.

These properties should be carefully considered when designing dissolution protocols, assay media, and long-term storage strategies.

Safe Handling and Storage Guidelines

Idarubicin HCl is a cytotoxic compound and a known DNA-damaging agent. Appropriate personal protective equipment (PPE) and containment measures are mandatory when working with this material in a research laboratory.

Personal Protective Equipment:

  • Wear chemotherapy-grade nitrile or latex gloves (double-gloving recommended).
  • Use a lab coat and eye protection at all times.
  • Prepare solutions inside a certified biological safety cabinet or chemical fume hood to minimise inhalation risk.

Spill Management: In case of a spill, absorb with inert material (e.g., vermiculite or dry sand), collect into a sealed container, and dispose of according to local cytotoxic waste regulations. Decontaminate affected surfaces with dilute sodium hypochlorite solution followed by water rinse.

Storage: Store the dry powder desiccated at -20 °C, protected from light. Prepared stock solutions should be aliquoted to avoid freeze-thaw cycles and stored at -80 °C for long-term stability. Record the date of preparation on each aliquot.

Waste Disposal: All waste containing Idarubicin HCl must be treated as cytotoxic/chemotherapy waste and disposed of in accordance with institutional and national regulations.

Solution Preparation and Experimental Protocols

Proper preparation of Idarubicin HCl stock and working solutions is critical to ensure reproducibility and compound integrity across experiments.

Stock Solution Preparation:

  1. Allow the vial to equilibrate to room temperature inside a desiccator before opening to prevent moisture condensation on the powder.
  2. Dissolve the compound in sterile, ultrapure water or DMSO to a concentration of 10 mM. Vortex gently and inspect visually for complete dissolution.
  3. Filter-sterilise aqueous solutions through a 0.22 µm membrane filter if sterility is required for cell-based assays.
  4. Aliquot immediately into amber microtubes to protect from light and store at -20 °C (short-term) or -80 °C (long-term).

Working Solution Dilution: Thaw a single aliquot immediately before use and dilute in pre-warmed cell culture medium to the desired working concentration (typically 10 nM–10 µM depending on the cell line and assay). Ensure the final DMSO concentration in culture medium does not exceed 0.1% (v/v) to avoid solvent cytotoxicity.

Typical In Vitro Applications:

  • Cytotoxicity assay (MTT/CCK-8): Treat cells at a concentration range of 1 nM–10 µM for 24–72 h to generate dose-response curves and determine IC50 values.
  • Apoptosis analysis (Annexin V/PI flow cytometry): Treat cells at IC50 concentration for 24–48 h, then harvest and stain according to kit instructions.
  • Cell cycle analysis: Fix treated cells in 70% ethanol, stain with propidium iodide, and analyse by flow cytometry to quantify G2/M arrest.
  • Western blot: Probe for γ-H2AX (DNA damage marker), cleaved caspase-3, and PARP cleavage to confirm mechanism of action.

Quality, Purity, and Regulatory Considerations

For reproducible research outcomes, the purity and quality of Idarubicin HCl are of paramount importance. Research-grade reagents should meet a minimum purity of ≥98% as determined by HPLC analysis. Each lot should be accompanied by a Certificate of Analysis (CoA) specifying purity, appearance, molecular weight confirmation, and storage conditions.

Lot-to-Lot Consistency: When comparing data across experiments conducted with different lots, researchers should verify purity data from the CoA and, where critical, perform an in-house NMR or MS verification of compound identity.

Regulatory Status: Idarubicin HCl supplied by Aladdin Scientific (SKU I408285) is intended strictly for in vitro research and preclinical laboratory use only. It is not approved for direct administration to humans or animals outside of licensed veterinary or clinical trial frameworks. Users are responsible for complying with all applicable institutional biosafety committee (IBC), institutional review board (IRB), and national regulatory requirements governing the use of cytotoxic substances.

Export and Import Controls: Researchers should verify whether local or international regulations impose export controls on cytotoxic research chemicals before ordering or transferring this compound across jurisdictions.

Frequently asked questions

What solvents are recommended for dissolving Idarubicin HCl?

Idarubicin HCl is freely soluble in water and DMSO. For cell-based assays, aqueous stock solutions (≥10 mg/mL) are preferred to minimise solvent effects. If DMSO is used, ensure the final concentration in culture medium does not exceed 0.1% (v/v). Avoid alkaline conditions that may degrade the glycosidic bond.

How should Idarubicin HCl stock solutions be stored to maintain stability?

Stock solutions of Idarubicin HCl should be aliquoted into amber or opaque microtubes immediately after preparation and stored at -20 °C for short-term use or at -80 °C for long-term storage. Repeated freeze-thaw cycles should be avoided as they can accelerate degradation. All solutions must be protected from light at all times.

What are the key safety precautions when handling Idarubicin HCl in the laboratory?

Idarubicin HCl is a cytotoxic DNA-damaging agent and must be handled with strict PPE including double nitrile gloves, a lab coat, and eye protection. All manipulations should be performed inside a certified biosafety cabinet or fume hood. Spills must be cleaned with dilute sodium hypochlorite, and all waste must be disposed of as cytotoxic waste in accordance with institutional and national regulations.

What concentration range is typically used for in vitro cytotoxicity studies with Idarubicin HCl?

For in vitro cytotoxicity assays such as MTT or CCK-8, Idarubicin HCl is typically tested across a concentration range of 1 nM to 10 µM over 24 to 72 hours of treatment, depending on the sensitivity of the cell line. IC50 values vary considerably between cell lines, so an initial broad dose-response experiment is recommended to identify the optimal working range.

References

  1. Aladdin Scientific Product Page: Idarubicin HCl, SKU I408285. Aladdin Scientific, Shanghai.
  2. Capranico G, Zunino F. DNA topoisomerase-trapping antitumour drugs. European Journal of Cancer. 1992;28A(12):2055-2060.
  3. Lown JW. Anthracycline and anthraquinone anticancer agents: current status and recent developments. Pharmacology & Therapeutics. 1993;60(2):185-214.
  4. Priebe W (ed). Anthracycline Antibiotics: New Analogues, Methods of Delivery, and Mechanisms of Action. American Chemical Society, Washington DC. 1995.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Categories: Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Cite this article

Aladdin Scientific. "Idarubicin HCl: Lab Handling & Research Use Guide" Aladdin Knowledge Base, updated 20.11.2026. https://www.aladdinsci.com/eu_de/faqs/idarubicin-hcl-lab-handling-research-use-guide-en.html
Was this article helpful? Yes No 0 out of found this helpful

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.